X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Gillette India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs GILLETTE INDIA - Comparison Results

GILLETTE INDIA 
   Change

Gillette India is the 52% subsidiary of US shaving major - Gillette USA. The company came back into the black in 2003 after a spate of restructuring in 2001 and 2002. Gillette hived off its battery manufacturing plant (Duracell) at Manesar and also s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES GILLETTE INDIA AMAR REMEDIES/
GILLETTE INDIA
 
P/E (TTM) x -0.5 65.9 - View Chart
P/BV x 0.1 20.1 0.3% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 AMAR REMEDIES   GILLETTE INDIA
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
GILLETTE INDIA
Jun-16
AMAR REMEDIES/
GILLETTE INDIA
5-Yr Chart
Click to enlarge
High Rs1645,650 2.9%   
Low Rs863,805 2.3%   
Sales per share (Unadj.) Rs261.6601.3 43.5%  
Earnings per share (Unadj.) Rs17.460.8 28.6%  
Cash flow per share (Unadj.) Rs22.370.1 31.8%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs100.7263.2 38.3%  
Shares outstanding (eoy) m26.1632.59 80.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.9 6.1%   
Avg P/E ratio x7.277.8 9.2%  
P/CF ratio (eoy) x5.667.4 8.3%  
Price / Book Value ratio x1.218.0 6.9%  
Dividend payout %032.9 0.0%   
Avg Mkt Cap Rs m3,270154,069 2.1%   
No. of employees `000NA0.6 0.0%   
Total wages/salary Rs m1631,090 15.0%   
Avg. sales/employee Rs ThNM30,335.3-  
Avg. wages/employee Rs ThNM1,686.7-  
Avg. net profit/employee Rs ThNM3,066.7-  
INCOME DATA
Net Sales Rs m6,84419,597 34.9%  
Other income Rs m21358 5.9%   
Total revenues Rs m6,86519,954 34.4%   
Gross profit Rs m1,1313,030 37.3%  
Depreciation Rs m128304 42.1%   
Interest Rs m39846 863.3%   
Profit before tax Rs m6263,038 20.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1211,057 11.5%   
Profit after tax Rs m4551,981 23.0%  
Gross profit margin %16.515.5 106.9%  
Effective tax rate %19.334.8 55.6%   
Net profit margin %6.610.1 65.8%  
BALANCE SHEET DATA
Current assets Rs m4,9049,732 50.4%   
Current liabilities Rs m3,5815,627 63.6%   
Net working cap to sales %19.320.9 92.3%  
Current ratio x1.41.7 79.2%  
Inventory Days Days12446 272.8%  
Debtors Days Days10020 489.9%  
Net fixed assets Rs m1,6892,740 61.7%   
Share capital Rs m262326 80.4%   
"Free" reserves Rs m2,3585,973 39.5%   
Net worth Rs m2,6358,578 30.7%   
Long term debt Rs m5070-   
Total assets Rs m6,86214,241 48.2%  
Interest coverage x2.666.9 3.8%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 72.5%   
Return on assets %12.414.2 87.3%  
Return on equity %17.323.1 74.8%  
Return on capital %31.036.0 86.2%  
Exports to sales %4.02.8 142.7%   
Imports to sales %015.6 0.0%   
Exports (fob) Rs m273548 49.9%   
Imports (cif) Rs mNA3,050 0.0%   
Fx inflow Rs m273585 46.7%   
Fx outflow Rs m23,479 0.1%   
Net fx Rs m271-2,894 -9.4%   
CASH FLOW
From Operations Rs m-3132,794 -11.2%  
From Investments Rs m-4891,550 -31.5%  
From Financial Activity Rs m769-786 -97.8%  
Net Cashflow Rs m-333,559 -0.9%  

Share Holding

Indian Promoters % 25.5 34.9 73.1%  
Foreign collaborators % 0.0 40.1 -  
Indian inst/Mut Fund % 9.2 0.9 1,022.2%  
FIIs % 0.0 7.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 16.3 400.6%  
Shareholders   13,061 18,623 70.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   JYOTHY LABS  HIND. UNILEVER  BAJAJ CORP  GODREJ INDUSTRIES  COLGATE  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS